2010 Industry Advocate of the Year: Harry Lattanzio

Harry Lattanzio, PRS Pharmacy Services
Published Online: Tuesday, March 22, 2011
Follow Pharmacy_Times:
Related Articles
The FDA has granted approval to Genzyme’s eliglustat (Cerdelga), the only first-line oral therapy for patients with Type 1 Gaucher disease.
Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy.
Ambulatory pharmacy practice will grow independent of community pharmacy practice, unless efforts are made to bring them closer together.
Latest Issues
$auto_registration$